Zevra Therapeutics, Inc. ZVRA Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s other income (expense)?
- Zevra Therapeutics, Inc. (ZVRA) reported other income (expense) of -$7.34M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Zevra Therapeutics, Inc.'s other income (expense) decreased by 313.1% year-over-year, from $3.45M to -$7.34M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s other income (expense)?
- Over 3 years (2021 to 2025), Zevra Therapeutics, Inc.'s other income (expense) has grown at a 108.9% compound annual growth rate (CAGR), from -$16.42M to $149.62M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.